itric Oxide Generator device for the treatment of Pulmonary Hypertensio
- Conditions
- Pulmonary Hypertension of the newbornC08.381.423M01.060.703.520
- Registration Number
- RBR-345m6j
- Lead Sponsor
- Hospital de Clínicas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Written parental consent to receive the proposed therapy; newborns greater than 34 weeks of gestational age; diagnostic of severe refractory hypoxemia receiving conventional intensive care supporting treatment; no access to any other kind of inhaled Nitric Oxide therapy; oxygenation index over 10; pre and post-ductal difference in pulsioximetry equal or over 5
Neonates with multiple malformations or malformations incompatible with extra uterine life. Lack of parental consent to receive the proposed therapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method